Drugs / Amoxicillin/clavulanate
last change Jan 2020 re-read 2 minutes ago

Amoxicillin/clavulanate

Developed for
bacterial infectious disease
Investigated by
Andalusian Public Foundation for Health Research in Seville · Spanish Network for Research in Infectious Diseases

Trials 1 · a red edge is where a trial was stopped

2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02795949 Oct 2016 → Jan 2020 bacterial infectious disease Andalusian Public Foundation for Health Research in Seville Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Amoxicillin/clavulanate Amoxicillin/clavulanate 1000/125 mg IV/8h” NCT02795949
Route Intravenous “Amoxicillin/clavulanate 1000/125 mg IV/8h” NCT02795949